Drug Shortage Report for TRISENOX
| Report ID | 15753 |
| Drug Identification Number | 02407833 |
| Brand name | TRISENOX |
| Common or Proper name | Arsenic Trioxide for Injection |
| Company Name | TEVA CANADA LIMITED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ARSENIC TRIOXIDE |
| Strength(s) | 1MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 10 mg/10mL ampoule |
| ATC code | L01XX |
| ATC description | OTHER ANTINEOPLASTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2017-09-08 |
| Actual start date | 2017-09-08 |
| Estimated end date | 2018-07-20 |
| Actual end date | 2018-07-24 |
| Shortage status | Resolved |
| Updated date | 2018-07-30 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v35 | 2018-07-30 | French | Compare |
| v34 | 2018-07-30 | English | Compare |
| v33 | 2017-12-15 | French | Compare |
| v32 | 2017-12-15 | English | Compare |
| v31 | 2017-12-15 | English | Compare |
| v30 | 2017-10-20 | French | Compare |
| v29 | 2017-10-20 | English | Compare |
| v28 | 2017-09-09 | English | Compare |
| v27 | 2017-08-23 | French | Compare |
| v26 | 2017-08-23 | English | Compare |
| v25 | 2017-08-10 | French | Compare |
| v24 | 2017-08-10 | English | Compare |
| v23 | 2017-07-28 | French | Compare |
| v22 | 2017-07-28 | English | Compare |
| v21 | 2017-07-27 | English | Compare |
| v20 | 2017-07-27 | French | Compare |
| v19 | 2017-07-27 | French | Compare |
| v18 | 2017-07-27 | English | Compare |
| v17 | 2017-07-27 | French | Compare |
| v16 | 2017-07-27 | French | Compare |